Top-News
  • Watchlist
  • Glocke
  • Handeln

    • CAC 40 Index News

    8.026,62 +0,52% +41,7016
    31.05.24 22:10:21 Ariva Indikation aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 969400
    ISIN: FR0003500008
    Typ: Index
    Weiter aufwärts? Long handeln - Jetzt mit Hebel 8,57: ME34E5

    Ad-hocs

    30.05.24 - Société Générale
    Verlängerung der Rally? Das spricht mittelfristig für steigende Kurse!
    Die verbesserten Konjunkturperspektiven im Euroraum und die weiter steigenden Trends für die erwarteten Unternehmensgewinne sprechen mittelfristig für weiter steigende ...  Mehr »
    23.05.24 - LYNX Analysen
    Hermès: Bullenflagge … oder mehr?
    Gerät eine Aktie ohne neue Nachrichten unter Druck und erstrecken sich die Abgaben auch noch auf die ganze Branche, neigt man schnell zu dem Gedanken, dass da jemand ...  Mehr »
    31.05.24 - GlobeNewswire
    Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
    Sanofi launches 2024 global Employee Stock Purchase Plan
    31.05.24 - GlobeNewswire
    Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
    Dupixent recommended for EU approval by the CHMP to treat patients with COPD Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data ...
    30.05.24 - GlobeNewswire
    Press Release: Sanofi completes acquisition of Inhibrx, Inc.
    Sanofi completes acquisition of Inhibrx, Inc.
    27.05.24 - GlobeNewswire
    Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myeloma
    Sarclisa accepted for FDA priority review for the treatment of transplant-​ineligible newly diagnosed multiple myeloma
    21.05.24 - GlobeNewswire
    Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
    Sanofi, Formation Bio and OpenAI announce first-​in-class AI collaboration
    20.05.24 - GlobeNewswire
    Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM
    Dupixent ® late-​breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM
    16.05.24 - GlobeNewswire
    Shareholders’ Meeting of May 16, 2024
    Media relations: Victoire Grux Tel. : +33 6 04 52 16 55 victoire.grux@capgemini.com
    10.05.24 - GlobeNewswire
    Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
    Sanofi and Novavax announce co-​exclusive licensing agreement to co-​commercialize COVID-19 vaccine and develop novel flu-​COVID-19 combination vaccines
    02.05.24 - GlobeNewswire
    ArcelorMittal S.A.: ArcelorMittal reports first quarter 2024 results
    Luxembourg, May 2 , 20 24 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the "Group") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world’s ...
    02.05.24 - GlobeNewswire
    Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations
    Beyfortus real-​world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations
    30.04.24 - GlobeNewswire
    ArcelorMittal announces results of its General Meeting
    30 April 2024, 18:15 CET
    30.04.24 - GlobeNewswire
    Press Release: Annual General Meeting of April 30, 2024
    Annual General Meeting of April 30, 2024
    30.04.24 - GlobeNewswire
    Capgemini records Q1 2024 revenues of €5.5 billion in line with expectations
    Media relations: Victoire Grux Tel.: +33 6 04 52 16 55 victoire.grux@capgemini.com
    25.04.24 - DGAP
    EQS-Adhoc: Airbus reports First Quarter (Q1) 2024 results
    EQS-​Ad-hoc: Airbus SE / Key word(s): Quarter Results Airbus reports First Quarter (Q1) 2024 results 25-Apr-2024 / 17:45 CET/CEST Disclosure of an inside information acc. to ...
    25.04.24 - GlobeNewswire
    ArcelorMittal S.A.: ArcelorMittal announces the publication of its first quarter 2024 sell-side analyst consensus figures
    25 April 2024, 14:30 CET
    25.04.24 - GlobeNewswire
    Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
    Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
    23.04.24 - GlobeNewswire
    ArcelorMittal S.A.: ArcelorMittal publishes its 2023 Integrated Annual Review
    23 April 2024, 15:00 CET
    23.04.24 - GlobeNewswire
    Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
    Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
    18.04.24 - GlobeNewswire
    First quarter 2024 sales
    A very good start to the year
    17.04.24 - GlobeNewswire
    Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
    New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis

    Newssuche

    Videos

    newspaper
    29.05.24
    Technical Trading: DAX Long Chance kurzfristig
    DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »